Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Osimertinib after definitive chemoradiotherapy in unresectable stage III epidermal growth factor receptor-mutated non-small-cell lung cancer: analyses of central nervous system efficacy and distant progression from the phase III LAURA study.
Lu S, Ahn MJ, Reungwetwattana T, Özgüroğlu M, Kato T, Yang JC, Huang M, Fujiki F, Inoue T, Quang LV, Sriuranpong V, Vicente D, Fuentes C, Chaudhry AA, Poole L, Armenteros Monterroso E, Rukazenkov Y, van der Gronde T, Ramalingam SS. Lu S, et al. Among authors: van der gronde t. Ann Oncol. 2024 Sep 11:S0923-7534(24)03823-7. doi: 10.1016/j.annonc.2024.08.2243. Online ahead of print. Ann Oncol. 2024. PMID: 39289145 Free article.
Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC.
Lu S, Kato T, Dong X, Ahn MJ, Quang LV, Soparattanapaisarn N, Inoue T, Wang CL, Huang M, Yang JC, Cobo M, Özgüroğlu M, Casarini I, Khiem DV, Sriuranpong V, Cronemberger E, Takahashi T, Runglodvatana Y, Chen M, Huang X, Grainger E, Ghiorghiu D, van der Gronde T, Ramalingam SS; LAURA Trial Investigators. Lu S, et al. Among authors: van der gronde t. N Engl J Med. 2024 Aug 15;391(7):585-597. doi: 10.1056/NEJMoa2402614. Epub 2024 Jun 2. N Engl J Med. 2024. PMID: 38828946 Clinical Trial.
Translation, psychometric validation, and baseline results of the Patient-Reported Outcomes Measurement Information System (PROMIS) pediatric measures to assess health-related quality of life of patients with pediatric lymphoma in Malawi.
Westmoreland K, Reeve BB, Amuquandoh A, van der Gronde T, Manthalu O, Correia H, Stanley C, Itimu S, Salima A, Chikasema M, Ward P, Mpasa A, Wachepa S, Mtete I, Butia M, Chasela M, Mtunda M, Wasswa P, Martin S, Kim NE, Kazembe P, Gopal S. Westmoreland K, et al. Among authors: van der gronde t. Pediatr Blood Cancer. 2018 Nov;65(11):e27353. doi: 10.1002/pbc.27353. Epub 2018 Jul 17. Pediatr Blood Cancer. 2018. PMID: 30015407
Response to proposal for a novel cancer drug pricing model.
van der Gronde T, Leufkens HG, Pieters T. van der Gronde T, et al. Nat Rev Clin Oncol. 2018 Aug;15(8):528. doi: 10.1038/s41571-018-0062-7. Nat Rev Clin Oncol. 2018. PMID: 29955112 No abstract available.
Assessing Pharmaceutical Research and Development Costs.
van der Gronde T, Pieters T. van der Gronde T, et al. JAMA Intern Med. 2018 Apr 1;178(4):587-588. doi: 10.1001/jamainternmed.2017.8706. JAMA Intern Med. 2018. PMID: 29610870 No abstract available.
Risk factors and reasons for treatment abandonment among children with lymphoma in Malawi.
Stanley CC, van der Gronde T, Westmoreland KD, Salima A, Amuquandoh A, Itimu S, Manda A, Mtete I, Butia M, Mpasa A, Wachepa S, Fox P, Wasswa P, Kazembe P, El-Mallawany NK, Gopal S. Stanley CC, et al. Among authors: van der gronde t. Support Care Cancer. 2018 Mar;26(3):967-973. doi: 10.1007/s00520-017-3917-z. Epub 2017 Oct 7. Support Care Cancer. 2018. PMID: 28986643 Free PMC article.
22 results